
AnaptysBio ANAB
$ 57.46
2.9%
AnaptysBio Historical Prices | ANAB
Annual Historical Prices AnaptysBio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.8 | 16.2 | 23.4 | 24.9 | 34.8 | 21.5 | 16.2 | 63.8 | 101 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 101 | 16.2 | 39.4 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
1.83 | - | -6.63 % | $ 13.9 M | ||
|
FSD Pharma
HUGE
|
1.31 | - | 5743.5 % | $ 69.7 M | ||
|
Codexis
CDXS
|
1.27 | $ 1.42 | 0.33 % | $ 124 M | ||
|
Synthetic Biologics
SYN
|
0.96 | - | 1.32 % | $ 16.2 M | ||
|
Dynavax Technologies Corporation
DVAX
|
13.3 | - | - | $ 2.02 B | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Corner Growth Acquisition Corp.
COOL
|
11.1 | - | -0.89 % | $ 114 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Qilian International Holding Group Limited
QLI
|
2.65 | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.22 | - | 1.35 % | $ 17.8 M | ||
|
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Cue Biopharma
CUE
|
0.31 | $ 27.67 | 2.63 % | $ 2.62 B | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.31 | - | 0.74 % | $ 768 M | ||
|
Abcam plc
ABCM
|
21.6 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
0.14 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Hepion Pharmaceuticals
HEPA
|
0.04 | - | -18.79 % | $ 39.3 K | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M | ||
|
Editas Medicine
EDIT
|
2.32 | $ 3.08 | 0.33 % | $ 273 M | ||
|
Ardelyx
ARDX
|
6.73 | $ 3.71 | 1.06 % | $ 894 M | ||
|
Affimed N.V.
AFMD
|
4.41 | - | -34.95 % | $ 21.5 M | ||
|
EyePoint Pharmaceuticals
EYPT
|
15.7 | $ 4.57 | 0.21 % | $ 335 K | ||
|
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 23.66 | 0.04 % | $ 3.01 B | ||
|
Assembly Biosciences
ASMB
|
27.5 | $ 36.13 | 4.38 % | $ 405 M | ||
|
Fate Therapeutics
FATE
|
1.57 | $ 2.42 | 0.61 % | $ 287 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
4.37 | - | -1.58 % | $ 28.1 M | ||
|
Celyad Oncology SA
CYAD
|
0.47 | - | - | $ 12.5 M | ||
|
Adial Pharmaceuticals
ADIL
|
1.96 | $ 6.66 | 5.38 % | $ 4.45 M | ||
|
Fortress Biotech
FBIO
|
2.79 | $ 2.71 | 0.04 % | $ 75.6 M | ||
|
Generation Bio Co.
GBIO
|
2.77 | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
Anika Therapeutics
ANIK
|
14.9 | $ 21.0 | 2.08 % | $ 301 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
4.9 | - | -4.36 % | $ 27 M | ||
|
Gracell Biotechnologies
GRCL
|
6.04 | - | - | $ 3.37 B | ||
|
Axsome Therapeutics
AXSM
|
174 | $ 208.35 | 0.16 % | $ 10.4 B | ||
|
GlycoMimetics
GLYC
|
0.28 | - | 9357.83 % | $ 1.01 B | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
BioMarin Pharmaceutical
BMRN
|
61 | $ 66.43 | 0.04 % | $ 12.7 B | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |